[1]
2024. Dilution of botulinum toxin type A in local anesthetics: a therapeutic opportunity in migraine treatment. Headache Medicine. 15, 2 (Jun. 2024), 43–46. DOI:https://doi.org/10.48208/HeadacheMed.2024.12.